title: Thermoradiotherapy in locally advanced deep seated tumours--thermal parameters and treatment results.
abstract: From October 1987 to December 1990 a total of 37 patients with deep seated tumours of the pelvis (n = 34), the abdomen (n = 2), or lower leg (n = 1) were treated with radiotherapy and regional hyperthermia. Hyperthermia was produced by the BSD-1000 system and the annular phased array (AA) applicator usually driven at 60-80 MHz, or the BSD-2000 system and the Sigma-60 (S 60) applicator usually driven at 70-90 MHz. Detailed thermal mapping and temperature analysis was performed on 29 patients. The overall mean maximum, average and minimum temperature observed was 42.9 +/- 2.4 degrees C, 40.9 +/- 1.5 degrees C, and 39.3 +/- 0.9 degrees C for all treatments. The time-averaged tumour temperatures achieved in 20%, 50% and 90% of all measured temperature sites were 41.8 +/- 2.1 degrees C (T20), 40.9 +/- 1.6 degrees C (T50), and 39.9 +/- 1.2 degrees C (T90). In addition, the overall mean maximum, average and minimum temperature measured in normal tissue was 42.4 +/- 1.4 degrees C, 40.6 +/- 1.0 degrees C, and 39.2 +/- 0.9 degrees C. The time averaged normal tissue temperatures achieved in 20%, 50% and 90% of all measured temperature sites were 41.3 +/- 1.1 degrees C, 40.6 +/- 1.1 degrees C, and 39.6 +/- 1.0 degrees C. In 36 assessable patients, the overall objective response rate was 31%: 2 complete responses (CR) and 9 partial responses (PR).
authors.affiliation: Department of Radiooncology, West German Tumour Centre, University Hospital, Essen.
authors.forename: H J
authors.initials: HJ
authors.lastname: Feldmann
authors.forename: M
authors.initials: M
authors.lastname: Molls
authors.forename: H G
authors.initials: HG
authors.lastname: Heinemann
authors.forename: R
authors.initials: R
authors.lastname: Romanowski
authors.forename: M
authors.initials: M
authors.lastname: Stuschke
authors.forename: H
authors.initials: H
authors.lastname: Sack
mesh_terms: D000328:Adult; D000368:Aged; D001831:Body Temperature; D003131:Combined Modality Therapy; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects; D008875:Middle Aged; D009369:Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*